Document Detail

Dyspnea in the advanced cancer patient.
MedLine Citation:
PMID:  9803048     Owner:  NLM     Status:  MEDLINE    
Optimal management of dyspnea in terminal cancer patients requires an understanding of the responsible pathophysiological mechanisms. This prospective study assessed visual analogue scales (VAS) of shortness of breath (SOB) and anxiety, bedside spirometry, maximum inspiratory pressure (MIP), chest radiography, arterial blood gases, hemoglobin, and electrocardiogram, if indicated, in 100 terminally ill cancer patients. Forty-nine percent of the patients had lung cancer. The median VAS scores for SOB and anxiety were 53 mm and 29 mm, respectively. Spirometry was abnormal in 93% of patients, with 5% having obstructive, 41% restrictive, and 47% mixed patterns. The median MIP was 16 cm H2O. Sixty-five percent of the patients had parenchymal or pleural involvement on chest radiograph. Twenty-nine percent had evidence of cardiac ischemia, recent or current myocardial infarction or atrial fibrillation. Patients had a median of five different abnormalities that could have contributed to their shortness of breath. Only anxiety (p = 0.001), a history of smoking (p = 0.02), and pCO2 levels were statistically significantly correlated with SOB VAS scores. The potentially correctable causes of dyspnea included hypoxia (40%), anemia (20%), and bronchospasm (52%). The finding of very low MIPs suggests severe respiratory muscle weakness may contribute significantly to dyspnea in this patient population. Further studies are needed to confirm this finding and characterize the underlying pathophysiology.
D J Dudgeon; M Lertzman
Related Documents :
7072588 - Clinical confirmation of ecg criteria for left atrial rhythm.
19487038 - Role of atrial fibrillation after transcatheter closure of patent foramen ovale in pati...
7659578 - Clinical and electrophysiological characteristics of atrial standstill.
7508598 - Does atrial fibrillation cause false-positive late potentials?
10468968 - Differences in the levels of tsh-binding inhibitor immunoglobulins in goitrous and agoi...
20071478 - Absence of major fibrotic adverse events in hyperprolactinemic patients treated with ca...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of pain and symptom management     Volume:  16     ISSN:  0885-3924     ISO Abbreviation:  J Pain Symptom Manage     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1998-12-01     Completed Date:  1998-12-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8605836     Medline TA:  J Pain Symptom Manage     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  212-9     Citation Subset:  IM    
Department of Internal Medicine, Queen's University, Kingston, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Dyspnea / etiology*
Middle Aged
Neoplasms / complications*
Prospective Studies
Comment In:
J Pain Symptom Manage. 1999 Nov;18(5):313-5   [PMID:  10584452 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, doub...
Next Document:  Prolonged treatment with transdermal fentanyl in neuropathic pain.